SFRP1 and benign prostatic hyperplasia: We observed that the SFRP1 expression was reduced in PCa samples compared with that in benign prostatic hyperplasia samples from 80% to 59% (Table 2) and its expression was inversely correlated with β-catenin expression (Table 3), consistent with their expression patterns in other tumor samples [16,37].